Your browser doesn't support javascript.
loading
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.
Frankell, Alexander M; Dietzen, Michelle; Al Bakir, Maise; Lim, Emilia L; Karasaki, Takahiro; Ward, Sophia; Veeriah, Selvaraju; Colliver, Emma; Huebner, Ariana; Bunkum, Abigail; Hill, Mark S; Grigoriadis, Kristiana; Moore, David A; Black, James R M; Liu, Wing Kin; Thol, Kerstin; Pich, Oriol; Watkins, Thomas B K; Naceur-Lombardelli, Cristina; Cook, Daniel E; Salgado, Roberto; Wilson, Gareth A; Bailey, Chris; Angelova, Mihaela; Bentham, Robert; Martínez-Ruiz, Carlos; Abbosh, Christopher; Nicholson, Andrew G; Le Quesne, John; Biswas, Dhruva; Rosenthal, Rachel; Puttick, Clare; Hessey, Sonya; Lee, Claudia; Prymas, Paulina; Toncheva, Antonia; Smith, Jon; Xing, Wei; Nicod, Jerome; Price, Gillian; Kerr, Keith M; Naidu, Babu; Middleton, Gary; Blyth, Kevin G; Fennell, Dean A; Forster, Martin D; Lee, Siow Ming; Falzon, Mary; Hewish, Madeleine; Shackcloth, Michael J.
Afiliação
  • Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Lim EL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Karasaki T; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Ward S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Bunkum A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Hill MS; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Grigoriadis K; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
  • Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Liu WK; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
  • Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Cook DE; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Salgado R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Wilson GA; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
  • Bailey C; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK.
  • Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Bentham R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Abbosh C; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Nicholson AG; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Le Quesne J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Biswas D; Department of Cellular Pathology, University College London Hospitals, London, UK.
  • Rosenthal R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Puttick C; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Lee C; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
  • Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Toncheva A; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Smith J; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Xing W; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Nicod J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Price G; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Kerr KM; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.
  • Naidu B; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Middleton G; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Blyth KG; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Fennell DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Forster MD; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Lee SM; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Falzon M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Hewish M; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Shackcloth MJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Nature ; 631(8022): E15, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38965439
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nature Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nature Ano de publicação: 2024 Tipo de documento: Article